Fibromyalgia Syndrome with Dr Maddy Piper

<p>Join us for this first episode in our podcast series about Fibromyalgia Syndrome (FMS). &nbsp;Listen along to the discussion as Mel Brooke, Patient and Public Engagement Programme Director (BIRD) talks with expert guest Dr Maddy Piper, Consultant Rheumatologist with interests in inflammatory arthritis, connective tissue diseases and fibromyalgia who explains about the symptoms and impacts that people with Fibro can experience, &nbsp;diagnostic techniques, treatments and self-management advice.</p> <p>If you can please rate our podcasts on your listening platform. &nbsp;Did you know you can also access all our information podcasts direct from BIRDs website? &nbsp;Simply visit <a href="https://www.birdbath.org.uk/podcasts">www.birdbath.org.uk/podcasts</a> and scroll down the page to find the one you are looking for.</p> <p>Links mentioned in the show:</p> <p>Fibromyalgia Action UK – <a href="http://www.fmauk.org/">www.fmauk.org</a></p> <p>Fibromyalgia Friends Together at <a href="https://fibro.org.uk/">https://fibro.org.uk</a>&nbsp;</p> <p>Fibromyalgia UK at <a href="https://fibromyalgiauk.co.uk">https://fibromyalgiauk.co.uk</a></p> <p>Versus Arthritis is a good source for information - <a href="https://www.versusarthritis.org/about-arthritis/conditions/fibromyalgia/">Fibromyalgia | Causes, symptoms, treatment | Versus Arthritis</a></p> <p>Please note: All content for BIRD's PPE podcasts are created for information purposes only and not intended to be a substitute for individual medical advice, diagnosis, or treatment. Always seek the advice of your physician or health provider with any questions you may have about your medical condition. Reliance on any information provided by BIRD or any of the expert podcast guests is solely at your own risk.</p> <p>The Patient and Public Engagement Programme is supported by hands-off&nbsp;sponsorships from Eli Lilly and Company Limited, UCB and Amgen - all of whom have provided grant funding but who have had no involvement in the development, content or editorial control of